3
Ecosystem Profile
3C Therapeutics
Develops proprietary DAC systems and next-generation cancer therapies.
1
Dispatches
Aug 10, 2026
Last Signal
Full Coverage Archive
3C Therapeutics Integrates Generative AI to Accelerate Design of Cancer Drug Candidates
3C Therapeutics Integrates Generative AI to Accelerate Design of Cancer Drug Candidates
The Vancouver-based company is utilizing a partnership with Variational AI to overcome the time constraints inherent in testing complex, antibody-based therapies.
Read article